Sodium Oxybate
Drug ingredientCAS 502-85-2
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
This chemical is listed as active in US commerce, but no company reported it to EPA’s survey for 2019 or 2023. Sites may have made or imported less than the threshold amount, or none.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 291819 · basket
These shares come from HS customs code 291819, which covers 96 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Switzerland
- Ukraine
- Colombia
- Taiwan
- Belgium
- Israel
- Sweden
- Hungary
- Ireland
- Slovakia
15 FDA-registered drug labelers
Why It Matters
Appears in 4 drug and cosmetic product listings (FDA).
- •sodium oxybate
- •Lumryz
- •Xyrem
- •Xywav
- to be discontinued
Sodium Oxybate Solution
Shortage listed since December 29, 2025
Chemical Identity
Data Sources
- PubChem · compound 23663870Retrieved 2026-04-07
- EPA TSCA InventoryRetrieved 2026-04-24
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Sodium Oxybate (CAS 502-85-2) https://chemicalindependence.com/chemical/502-85-2/ PubChem: 23663870. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/23663870 EPA TSCA Inventory: CAS 502-85-2. Retrieved 2026-04-24. https://www.epa.gov/tsca-inventory FDA Drug Shortages: CAS 502-85-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 291819 for CAS 502-85-2. Reporting year: 2024. https://usatrade.census.gov/